Article
Best practices in epidermal growth factor receptor T790M testing for advanced non-small-cell lung cancer in Hong Kong.
Hong Kong medical journal = Xianggang yi xue za zhi - 1 Jun 2023
Nyaw J S F, Cheung K M, Hioe F, Kam M T Y, Lau J K S, Lau Y M, Leung D K C, Lim F M Y
Abstract excerpt
The T790M mutation in the epidermal growth factor receptor gene causes most acquired resistance to firstor second-line epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small-cell lung cancer. The results of T790M testing can guide subsequent treatment. Despite the availability of guidelines from international organisations, T790M testing practices in Hong Kong must be streamlined and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
